Value of diagnostic tools for myocardial ischemia used in routine clinical practice to predict cardiac events in patients with type 2 diabetes mellitus: A prospective study

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 1, 2006, Pages 46-52

  De Azevedo, Mirela J ^a   Neto, André F R ^a   Caramori, Maria Luiza A ^a   Beck, Maristela O ^a   Moreira, Juliano S R ^a   Ludwig, Roberto ^a   Gross, Jorge L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Cardiac events; Coronary artery disease; Risk factors; Type 2 diabetes

Indexed keywords

EID: 33646722440     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302006000100007     Document Type: Article

References (22)

1. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987;30:123-31.
2. Stamler J, Vacarro O, Neaton J, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened for the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-49.
3. Haffner SM, Lehto S, Ronnemaa T, Pyorälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
4. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassman-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999;22:1396-404.
5. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:170-5.
6. Beck MO, Silveiro SP, Friedman R, Clausell N, Gross JL. Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care 1999;22:1745-7.
7. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou PY, Cordonnier D, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19-26.
8. Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002;25:1042-8.
9. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
10. Faglia E, Favales F, Calia P, Paleari F, Segaline G, Gamba PL, et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002;25:2032-6.
11. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. WHO Monograph Series #56, 2nd ed. WHO, England, 1982, pp.123-65.
12. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-82.
13. American Diabetes Association: Nephropathy in Diabetes. Position Statement. Diabetes Care 2004;27(suppl 1):S79-83.
14. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field studies. Bull World Health Organ 1962;27:645-58.
15. Fischbacher CM, Bhopal R, Unwin N, White M, Alberti KG. The performance of the Rose angina questionnaire in South Asian and European origin populations: A comparative study in Newcastle, UK. Int J Epidemiol 2001;30:1009-16.
16. Evans JMM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: Cross sectional and cohort studies. Brit Med J 2002;324:939-42.
17. Koistinen MJ, Huikuri HV, Pirttiaho H, Linnaluoto MK, Takkunen JT. Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients. Br Heart J 1990;63:7-11.
18. Cohen MC, Curran PJ, L'Italien GJ, Mittleman MA, Zarich SW. Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am J Cardiol 1999;83:1038-42.
19. Nesto RW. Screening for coronary artery disease in diabetes. Diabetes Care 1999;22:1393-5.
20. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes 2001;50:1180-5.
21. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995-1001.
22. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.